LncRNA RP11-19E11 is an E2F1 target required for proliferation and survival of basal breast cancer
Ariadna Giró‐Perafita(Universitat de Girona), Francisco J. Esteva(The University of Texas MD Anderson Cancer Center)
Cited by 33
Related Papers
PTEN, PIK3CA, p-AKT, and p-p70S6K Status
|American Journal Of Pathology|2010|285
Phase I/II Study of Trastuzumab in Combination With Everolimus (RAD001) in Patients With HER2-Overexpressing Metastatic Breast Cancer Who Progressed on Trastuzumab-Based Therapy
|Journal of Clinical Oncology|2011|211
Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells
|Breast Cancer Research|2010|137